MedTrace Logo

Magnetic Seizure Therapy (MST) for the Treatment of Major Depression

NCT00973934 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2014-06-10

No results posted yet for this study

Summary

This two-center, between-subject, randomized, double-masked study (n=20) will provide the first evidence for the antidepressant efficacy of Magnetic Seizure Therapy (MST) and contrast the therapeutic properties and side effects of two forms of MST in patients in a major depressive episode (MDE).

Conditions

Interventions

DEVICE

Magstim Theta

DEVICE

Thymatron System IV

Sponsors & Collaborators

  • University of Texas

    collaborator OTHER

  • Stanley Medical Research Institute

    collaborator OTHER

  • Sarah Lisanby

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-04-30
Primary Completion
2006-01-31
Completion
2009-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00973934 on ClinicalTrials.gov